However, recently, KRT9 has been shown to occur in many other tissues and has also been associated with bladder cancer (34), gastric cancer (35), TAMG (+) thymomas (37), primary melanoma, and benign nevi (36). This evidence concerns the gene KRT9 and urinary bladder carcinoma.